|
| ID |
DDInter1940 |
| Drug Type |
small molecule |
| Molecular Formula |
C19H14Cl2N2O3S |
| Molecular Weight |
421.304
|
| Description |
Vismodegib is a hedgehog pathway inhibitor used to treat patients with locally advanced or metastatic basal cell carcinoma.
|
| ATC Classification |
L01XX43
|
| IUPAC Name |
2-Chloro-N-[4-Chloro-3-(Pyridin-2-Yl)Phenyl]-4-Methanesulfonylbenzamide |
| InChI |
Inchi=1S/C19H14Cl2N2O3S/C1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/H2-11H,1H3,(H,23,24) |
| InChI Key |
BPQMGSKTAYIVFO-UHFFFAOYSA-N |
| Canonical SMILES |
CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|